Lumira Ventures

Lumira Ventures is a North American healthcare venture capital firm with over two decades of experience investing in transformative biomedical companies. Established in 2007, the firm operates from offices in Toronto, Montréal, Vancouver, and Boston. Lumira Ventures focuses on biotechnology, medical devices, and digital health sectors, partnering with mission-driven entrepreneurs to develop innovative therapeutic solutions.

The firm employs a multi-stage investment approach, typically investing between $5 million and $15 million in companies at various stages of development. Lumira Ventures has a history of successful exits, including landmark FDA product approvals and significant IPOs. Their portfolio companies have collectively impacted the lives of over 1 billion patients worldwide and generated more than $75 billion in cumulative revenue.

Lumira Ventures differentiates itself by assisting portfolio companies in leveraging its multi-decade team stability, global industry relationships, and lessons learned from building over 100 companies. The firm is committed to building companies that deliver impact to patients and healthcare systems worldwide, leveraging its experience and broad network to maximize the value, growth, and impact of its portfolio companies.